Counter-Drone Award Adds to Backlog but Does Not Resolve Conversion Risk

What happened

Raytheon, an RTX business, was awarded $729 million to deliver LIDS counter-drone system components to the U.S. Army, Qatar, and Jordan, adding to RTX's already record-high defense backlog of $119 billion as of June 30, 2026. The award is consistent with strong demand for missile-defense and counter-UAS systems, but it represents only a small fraction of total backlog and does not address the company's core challenge of converting bookings into delivered revenue and cash. RTX's 10-Q filings continue to highlight supply-chain disruptions, rare earth and microelectronics shortages, and tariff risks that pressure estimates-at-completion and margin performance. At the current price of $217.90, the stock trades at 37.9x earnings and 21.7x EV/EBITDA, already pricing in robust defense demand and aftermarket strength, leaving little room for error. Therefore, this contract announcement is incrementally positive for backlog but does not change the WAIT thesis, which hinges on execution rather than order intake.

Implication

Investors should view this award as confirmation of strong defense demand for counter-drone capabilities, but note that similar demand has been evident in prior quarters and is already reflected in the stock's elevated multiples. The critical factor for RTX remains whether it can translate its $289 billion total backlog into revenue and free cash flow without margin erosion from tariffs and supplier shortages. If the company can demonstrate improved delivery throughput and maintain margin discipline, the stock may deserve a higher multiple; however, if conversion stalls, the stock could de-rate significantly. Given the current valuation, the risk-reward is unattractive for new longs; a better entry point would be near the $195 level identified in the master report. Over the next few quarters, monitor quarterly free cash flow, Raytheon segment margins, and management commentary on supply-chain pressures to assess whether the thesis is improving.

Thesis delta

This contract award supports the defense demand pillar of the RTX thesis but does not address the central concern of production and delivery conversion. No material shift in the investment thesis occurs, as the WAIT rating remains appropriate given full valuation and execution risk. Continue to monitor for evidence of accelerating defense sales growth alongside sustained margin levels.